author-photo

Jennifer Savoie

Harvard University

18

Papers

327

Citations

Citation Trend

Filter By

Papers (14) Sort By

Journal Conference Others

Barriers to Clinical Trial Accrual: Perspectives of Community-Based Providers

2020 Clinical Breast Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer.

2020 Breast Cancer Research
Show All
- Source
- Cite
- Save
Citations (10)
Abstract 4564: The immune microenvironment in hormone receptor-positive breast cancer and treatment outcome following preoperative chemotherapy plus bevacizumab

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Immune biomarkers and treatment (tx) outcome in hormone receptor-positive (HR+) breast cancer (BC) patients (pts) treated with preoperative chemotherapy (preop chemo) plus bevacizumab (bev).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P2-15-03: A Phase Ib Study of an adjuvant GM-CSF-Secreting Breast Cancer Vaccine

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer

2013 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (6)
A randomized controlled trial of oral melatonin supplementation and breast cancer biomarkers.

2012 Cancer Causes & Control
Show All
- Source
- Cite
- Save
Citations (33)
PD05-07: Prospective Validation and Characterization of HER2 Positive Circulating Tumor Cells in Patients with HER2 Negative Metastatic Breast Cancer.

2011 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract LB-431: Randomized trial of oral melatonin supplementation in breast cancer survivors

2010 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
A phase I study of vandetanib and metronomic chemotherapy in advanced breast cancer.

2009 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)